| ²é¿´: 656 | »Ø¸´: 0 | ||
zhangy_1977ͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
FDAȱÏÝÐÅÖеĶÔÕÕÆ·Ò»ÖÂÐÔ
|
|
×î½ü¿´µ½Ò»¸öFDAµÄȱÏÝÐÅÎÊÌ⣬ÈçÏ¡£ OBSERVATION 4 Laboratory controls do not include the establishment of scientijfically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity. Specifically, during the establishment o f system suitability for chromatographic analyses, the firm did not prepare or use a second working standard solution (Check Standard Solution) to confirm the potency, accuracy and purity of the working standard solutions (Primary Standard Solution). A single standard preparation was used to determine the potency, accuracy and purity of the active pharmaceutical ingredient in the sample solution. ÎÊÏ´óÉñ£¬Õâ¸öÔõô×ö£¬ÊÇÓÃÒ»¸ö¶ÔÕÕÆ·£¬Åä³ÉÁ½¸ö¶ÔÕÕÈÜÒº£¬½øÐбȽϣ¿»¹ÊÇÓÃÁ½¸ö¶ÔÕÕÆ··Ö±ðÅä³ÉÁ½¸ö¶ÔÕÕÈÜÒº½øÐбȽϰ¡£¿µÚÒ»¸ö¶ÔÕÕÓëµÚ¶þ¸ö¶ÔÕÕÈÜÒºÈçºÎ¼ÆËã±È½Ï£¿ |
» ²ÂÄãϲ»¶
319Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ15È˻ظ´
085600£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
085600µ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319
ÒѾÓÐ26È˻ظ´
0703»¯Ñ§
ÒѾÓÐ5È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄÏÅ©090401£¬268£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
323Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´















»Ø¸´´ËÂ¥